Keros Therapeutics CEO Jasbir Seehra's 2021 pay falls 24% to $7.2M
Keros Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 18, 2022
Keros Therapeutics reported fiscal year 2021 executive compensation information on April 18, 2022.
In 2021, three executives at Keros Therapeutics received on average a compensation package of $4.3M, a 16% decrease compared to previous year.
Average pay of disclosed executives at Keros Therapeutics
Jasbir Seehra, Chief Executive Officer, received $7.2M in total, which decreased by 24% compared to 2020. 87% of Seehra's compensation, or $6.3M, was in option awards. Seehra also received $348K in non-equity incentive plan, $557K in salary, as well as $3.3K in other compensation.
Keith Regnante, Chief Financial Officer, received a compensation package of $3M, which increased by 29% compared to previous year. 80% of the compensation package, or $2.4M, was in option awards.
Jennifer Lachey, Chief Scientific Officer, earned $2.7M in 2021, a 24% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 18, 2022.